" class="no-js "lang="en-US"> Lecanemab Archives - Medtech Alert
Saturday, February 04, 2023

Sort by:

Date

Top Post

NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition

The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]

BioArctic: Lecanemab Receives Priority Review Status in Japan

BioArctic AB’s partner Eisai has announced that the application for manufacturing and marketing approval for […]

European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer's disease

BioArctic AB‘s partner Eisai have announced that the European Medicines Agency (EMA) has accepted a […]

Eisai Submits Marketing Application for lecanemab for Alzheimer's

BioArctic AB’s partner Eisai announced today that Eisai has submitted a marketing authorization application for […]

Eisai Submits Marketing Autherization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Europe

Eisai and Biogen have announced that Eisai has submitted a marketing authorization application (MAA) for […]

  1. Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
  2. Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
  3. Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
  4. Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
  5. Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more